EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Targeted delivery of TAPI-1 via biomimetic nanoparticles ameliorates post-infarct left ventricle function and remodelling

Qing Chen, Yang Yu, Lei Tong, Robert M Weiss, Shun-Guang Wei iD

Cardiovascular Research · 23.05.2025 · 121 (5) · 760-774

DOI: 10.1093/cvr/cvaf039 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cardiovascular Research, online erschienen am 05.03.2025. Verfasst von Qing Chen und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, University of Iowa Carver College of Medicine, 200 Hawkins Drive, Iowa City, IA 52242, USA. Hauptthemen laut MEDLINE: Ventricular Remodeling, Myocardial Infarction, Ventricular Function, Left, Nanoparticles. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NHLBI NIH HHS, NIH HHS, National Heart, Lung, and Blood Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

The potential of nanoparticles as effective drug delivery tools for treating failing hearts in heart failure remains a challenge. Leveraging the rapid infiltration of neutrophils into infarcted hearts after myocardial infarction (MI), we developed a nanoparticle platform engineered with neutrophil membrane proteins for the targeted delivery of TAPI-1, a TACE/ADAM17 inhibitor, to the inflamed myocardium, aiming to treat cardiac dysfunction and remodelling in rats with MI. Methods and results Neutrophil-mimic liposomal nanoparticles (Neu-LNPs) were constructed by integrating synthesized liposomal nanoparticles with LPS-stimulated neutrophil membrane fragments and then loaded with TAPI-1. MI rats were treated with TAPI-1 delivered via Neu-LNPs for 4 weeks. Left ventricular function was assessed by echocardiography and cardiac fibrosis was evaluated post-treatment. The novel Neu-LNPs maintained typical nanoparticle features, but with increased biocompatibility. Neu-LNPs demonstrated improved targeting ability and cellular internalization, facilitated by LFA1/Mac1/ICAM-1 interaction. Neu-LNPs displayed higher accumulation and cellular uptake by macrophages and cardiomyocytes in infarcted hearts post-MI, with a sustained duration. Treatments with TAPI-1-Neu-LNPs demonstrated greater protection against myocardial injury and cardiac dysfunction in MI rats compared to untargeted TAPI-1, along with reduced cardiac collagen deposition and expression of fibrosis biomarkers as well as altered immune cell compositions within the hearts.

Conclusions

Targeted treatment with TACE/ADAM17 inhibitor delivered via biomimetic nanoparticles exhibited pronounced advantages in improving left ventricle function, mitigating cardiac remodelling, and reducing inflammatory responses within the infarcted hearts. This study underscores the effectiveness of Neu-LNPs as a drug delivery strategy to enhance therapeutic efficacy in clinical settings.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Ventricular RemodelingMyocardial InfarctionVentricular Function, LeftNanoparticlesBiomimetic MaterialsAnti-Inflammatory AgentsNanoparticle Drug Delivery SystemAnimalsDisease Models, AnimalMaleFibrosisRats, Sprague-DawleyLiposomesADAM17 ProteinNeutrophilsRecovery of FunctionNeutrophil InfiltrationBiomimeticsMyocytes, Cardiac

Stichwörter der Autor:innen

Drug deliveryInflammationMyocardial infarctionNanotechnologyTACE/ADAM17

Substanzen

LiposomesADAM17 ProteinAnti-Inflammatory AgentsNanoparticle Drug Delivery System

Autor:innen und Institutionen

  • Department of Internal Medicine, University of Iowa Carver College of Medicine, 200 Hawkins Drive, Iowa City, IA 52242, USA.
  • Abboud Cardiovascular Research Center, University of Iowa Carver College of Medicine, 501 Newton Road, Iowa City, IA 52242, USA.
  • Veteran Affairs Medical Center, Research and Development, 601 HWY 6 WEST, Iowa City, IA 52246, USA.
  • Iowa Neuroscience Institute, University of Iowa, 169 Newton Road, Iowa City, IA 52242, USA.

ORCID-Profile: Shun-Guang Wei

Förderung

  • NHLBI NIH HHS
  • NIH HHS
  • National Heart, Lung, and Blood Institute
  • National Institutes of Health

Zitieren

APA

Chen, Q., Yu, Y., Tong, L., Weiss, R. M., & Wei, S. G. (2025). Targeted delivery of TAPI-1 via biomimetic nanoparticles ameliorates post-infarct left ventricle function and remodelling. Cardiovascular Research, 121(5), 760-774. https://doi.org/10.1093/cvr/cvaf039

Vancouver

Chen Q, Yu Y, Tong L, Weiss RM, Wei SG. Targeted delivery of TAPI-1 via biomimetic nanoparticles ameliorates post-infarct left ventricle function and remodelling. Cardiovascular Research. 2025;121(5):760-774. doi:10.1093/cvr/cvaf039

BibTeX
@article{Chen2025,
  author = {Chen, Qing and Yu, Yang and Tong, Lei and Weiss, Robert M and Wei, Shun-Guang},
  title = {Targeted delivery of TAPI-1 via biomimetic nanoparticles ameliorates post-infarct left ventricle function and remodelling},
  journal = {Cardiovascular Research},
  year = {2025},
  volume = {121},
  number = {5},
  pages = {760--774},
  doi = {10.1093/cvr/cvaf039}
}
Kostenlos starten →